Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Brandon Mcmahon

Concepts (259)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myeloproliferative Disorders
9
2022
27
1.420
Why?
Thrombosis
6
2019
371
1.390
Why?
Primary Myelofibrosis
3
2025
10
1.180
Why?
Urokinase-Type Plasminogen Activator
4
2015
29
1.020
Why?
Plasminogen Activator Inhibitor 1
3
2015
86
0.920
Why?
Thrombocytopenia
3
2016
200
0.890
Why?
Neoplasms
9
2021
2671
0.870
Why?
Pyrazoles
3
2025
423
0.840
Why?
Anticoagulants
5
2021
664
0.830
Why?
Hemorrhage
5
2018
722
0.810
Why?
Plasminogen
3
2013
30
0.720
Why?
Fibrinolysin
2
2013
20
0.710
Why?
Blood Platelets
3
2025
408
0.650
Why?
Receptors, Urokinase Plasminogen Activator
2
2015
15
0.540
Why?
Liver Cirrhosis
2
2020
316
0.510
Why?
Anemia, Pernicious
1
2016
9
0.510
Why?
Pancytopenia
1
2016
8
0.500
Why?
Hypothyroidism
1
2016
72
0.480
Why?
Neoplasm Proteins
2
2009
434
0.480
Why?
Myelodysplastic Syndromes
2
2016
135
0.470
Why?
Unnecessary Procedures
1
2014
50
0.430
Why?
Tissue Inhibitor of Metalloproteinase-2
1
2013
15
0.400
Why?
Heparin
1
2014
261
0.400
Why?
Enzyme-Linked Immunosorbent Assay
1
2014
852
0.380
Why?
Thrombophilia
2
2009
83
0.370
Why?
Medical Oncology
5
2022
289
0.360
Why?
Polycythemia Vera
4
2022
12
0.350
Why?
Fibrinolysis
2
2009
146
0.340
Why?
Nitriles
2
2025
172
0.310
Why?
Interferon Type I
3
2015
140
0.300
Why?
Biomarkers, Tumor
2
2018
1276
0.300
Why?
Tissue Plasminogen Activator
2
2009
224
0.280
Why?
Tumor Necrosis Factor-alpha
2
2025
1242
0.270
Why?
Antineoplastic Agents
5
2018
2129
0.270
Why?
Pyrimidines
2
2025
470
0.260
Why?
Intracellular Signaling Peptides and Proteins
3
2015
455
0.250
Why?
Venous Thromboembolism
2
2021
316
0.250
Why?
Qa-SNARE Proteins
1
2025
20
0.240
Why?
Humans
38
2025
137585
0.220
Why?
Fetomaternal Transfusion
1
2023
11
0.210
Why?
Thrombocythemia, Essential
1
2022
7
0.200
Why?
Down-Regulation
1
2025
657
0.200
Why?
Autophagy
1
2025
284
0.200
Why?
Interferon-alpha
2
2014
198
0.200
Why?
MAP Kinase Signaling System
2
2015
320
0.180
Why?
Telomerase
2
2020
250
0.180
Why?
Graft vs Host Disease
1
2023
252
0.180
Why?
Venous Thrombosis
1
2021
190
0.160
Why?
Mastocytosis, Systemic
1
2018
8
0.150
Why?
Mutation
4
2020
3958
0.150
Why?
Treatment Outcome
6
2025
10811
0.150
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
53
0.150
Why?
Pregnancy Complications
1
2023
527
0.140
Why?
Chicago
2
2016
61
0.140
Why?
Eosinophilia
1
2020
218
0.140
Why?
Risk Factors
5
2021
10388
0.140
Why?
Gene Rearrangement
1
2018
150
0.140
Why?
Mitochondria
2
2025
948
0.140
Why?
Anaphylaxis
1
2018
105
0.130
Why?
Neovascularization, Pathologic
2
2009
301
0.130
Why?
Janus Kinase 2
2
2015
32
0.130
Why?
Aging
2
2019
1864
0.130
Why?
Aged, 80 and over
3
2025
7635
0.130
Why?
Neoplasm Metastasis
2
2009
658
0.120
Why?
Philadelphia Chromosome
1
2016
18
0.120
Why?
Biomarkers
3
2018
4149
0.120
Why?
Vitamin B 12 Deficiency
1
2016
81
0.120
Why?
Anemia, Iron-Deficiency
1
2016
58
0.120
Why?
Fusion Proteins, bcr-abl
1
2015
69
0.120
Why?
Vitamin B 12
1
2016
128
0.120
Why?
Thienamycins
1
2015
5
0.120
Why?
Inactivation, Metabolic
1
2015
11
0.120
Why?
Piperacillin
1
2015
9
0.120
Why?
Anemia, Hemolytic
1
2015
20
0.120
Why?
Vitamin K
1
2015
45
0.110
Why?
Age Factors
4
2015
3295
0.110
Why?
False Positive Reactions
1
2014
115
0.110
Why?
Aged
5
2025
23961
0.110
Why?
Cell Movement
2
2009
967
0.110
Why?
Hemostasis
1
2014
82
0.110
Why?
Bone Marrow Neoplasms
1
2013
3
0.110
Why?
Signal Transduction
4
2016
5079
0.110
Why?
Drug Hypersensitivity
1
2015
90
0.100
Why?
Patient Care Team
1
2018
631
0.100
Why?
Drug Monitoring
1
2015
218
0.100
Why?
Blood Transfusion
1
2016
325
0.100
Why?
Chi-Square Distribution
1
2014
530
0.100
Why?
Thrombocytosis
1
2012
6
0.100
Why?
Leukocytosis
1
2012
30
0.100
Why?
Adult
10
2022
37929
0.100
Why?
Academic Medical Centers
1
2016
512
0.100
Why?
Interferon-beta
1
2013
92
0.100
Why?
Pseudomonas Infections
1
2015
225
0.100
Why?
Middle Aged
6
2025
33479
0.100
Why?
Receptor, Interferon alpha-beta
1
2012
34
0.100
Why?
Liver Transplantation
1
2020
871
0.100
Why?
Female
10
2025
73304
0.100
Why?
Administration, Oral
1
2015
816
0.100
Why?
Antibodies
1
2014
410
0.100
Why?
Predictive Value of Tests
2
2015
2031
0.100
Why?
Annexin A2
2
2009
16
0.100
Why?
Kaplan-Meier Estimate
1
2014
889
0.090
Why?
Prognosis
3
2016
4030
0.090
Why?
Gene Expression Regulation, Neoplastic
2
2015
1396
0.090
Why?
Animals
9
2025
36940
0.090
Why?
Respiratory Tract Infections
1
2015
390
0.080
Why?
RNA-Binding Proteins
1
2014
422
0.080
Why?
Male
9
2025
67762
0.080
Why?
Mice
7
2025
17787
0.080
Why?
Phosphoproteins
1
2012
338
0.080
Why?
Apoptosis
2
2009
2553
0.080
Why?
Leukemia, Myeloid, Acute
1
2016
630
0.080
Why?
Carrier Proteins
1
2014
771
0.080
Why?
Nuclear Proteins
1
2014
712
0.080
Why?
Leukemia, Promyelocytic, Acute
1
2009
11
0.080
Why?
Cryoglobulins
1
2009
6
0.080
Why?
Carboxypeptidase B2
1
2009
3
0.080
Why?
Plasminogen Inactivators
1
2009
3
0.080
Why?
Receptors, Peptide
1
2009
17
0.080
Why?
Anemia, Hemolytic, Autoimmune
1
2009
14
0.080
Why?
Blood Group Antigens
1
2009
15
0.080
Why?
Cerebral Infarction
1
2009
44
0.080
Why?
Factor VII
1
2008
24
0.080
Why?
Edetic Acid
1
2008
50
0.080
Why?
Disease Progression
3
2015
2757
0.070
Why?
Nerve Tissue Proteins
1
2012
596
0.070
Why?
von Willebrand Factor
1
2008
80
0.070
Why?
Multiple Organ Failure
1
2009
128
0.070
Why?
Factor VIII
1
2008
98
0.070
Why?
Inflammation
1
2019
2837
0.070
Why?
Time Factors
2
2018
6828
0.070
Why?
Oncogene Proteins, Fusion
2
2020
215
0.070
Why?
Immunoglobulin M
1
2009
289
0.070
Why?
Transcription, Genetic
1
2014
1457
0.070
Why?
Bone Marrow
2
2018
286
0.070
Why?
Neoplasm Invasiveness
1
2009
510
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2009
382
0.070
Why?
Practice Patterns, Physicians'
1
2016
1313
0.070
Why?
Cell Division
1
2009
794
0.070
Why?
Blood Coagulation Disorders
1
2009
173
0.070
Why?
Membrane Proteins
1
2012
1164
0.060
Why?
Intestines
1
2009
357
0.060
Why?
Ischemia
1
2009
409
0.060
Why?
Hematopoietic Stem Cell Transplantation
2
2023
622
0.060
Why?
Cytokines
2
2014
2085
0.060
Why?
Cystic Fibrosis
1
2015
1114
0.060
Why?
Biopsy
2
2018
1129
0.060
Why?
Retrospective Studies
4
2016
15657
0.060
Why?
Janus Kinases
2
2016
15
0.060
Why?
Erythroid Cells
2
2015
10
0.060
Why?
Anti-Bacterial Agents
1
2015
1809
0.060
Why?
Societies, Medical
2
2018
820
0.050
Why?
Molecular Targeted Therapy
2
2018
411
0.050
Why?
Immunosuppressive Agents
1
2009
890
0.050
Why?
Hepatitis B virus
1
2003
40
0.050
Why?
Mice, Knockout
2
2025
3015
0.050
Why?
Virus Integration
1
2003
71
0.050
Why?
p38 Mitogen-Activated Protein Kinases
2
2015
283
0.050
Why?
Papillomaviridae
1
2003
125
0.050
Why?
Antibodies, Monoclonal
1
2009
1430
0.050
Why?
Survival Analysis
2
2018
1325
0.040
Why?
Protein Kinase Inhibitors
2
2018
916
0.040
Why?
Autoantibodies
1
2009
1496
0.040
Why?
Combined Modality Therapy
2
2017
1236
0.040
Why?
Uterine Cervical Neoplasms
1
2003
257
0.040
Why?
Hematopoietic Stem Cells
2
2014
406
0.040
Why?
Megakaryocytes
1
2019
34
0.040
Why?
Phosphorylation
2
2014
1759
0.040
Why?
Histamine Antagonists
1
2018
21
0.040
Why?
mRNA Cleavage and Polyadenylation Factors
1
2018
29
0.040
Why?
Platelet Activation
1
2019
93
0.040
Why?
Fetus
1
2023
806
0.040
Why?
Glomerulonephritis, IGA
1
2018
11
0.040
Why?
Proto-Oncogene Proteins c-kit
1
2018
67
0.040
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2018
44
0.040
Why?
Fibroblasts
2
2014
996
0.040
Why?
Transplantation, Homologous
1
2018
416
0.030
Why?
Mast Cells
1
2018
147
0.030
Why?
Immunophenotyping
1
2018
318
0.030
Why?
Prevalence
2
2015
2734
0.030
Why?
Liver Neoplasms
1
2003
786
0.030
Why?
Receptors, Thrombopoietin
1
2016
6
0.030
Why?
Thrombopoietin
1
2016
5
0.030
Why?
Cell Line, Tumor
2
2015
3412
0.030
Why?
Cells, Cultured
2
2015
4193
0.030
Why?
Benzoates
1
2016
43
0.030
Why?
Drug Administration Schedule
1
2018
786
0.030
Why?
Hydrazines
1
2016
35
0.030
Why?
Antimetabolites, Antineoplastic
1
2016
94
0.030
Why?
Receptors, Fc
1
2016
53
0.030
Why?
General Practice
1
2016
29
0.030
Why?
Platelet Count
1
2015
86
0.030
Why?
Drug Therapy, Combination
1
2018
1066
0.030
Why?
Autophagy-Related Protein-1 Homolog
1
2015
7
0.030
Why?
Azacitidine
1
2016
140
0.030
Why?
Immunologic Tests
1
2015
16
0.030
Why?
Interferon Regulatory Factors
1
2015
39
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
539
0.030
Why?
Response Elements
1
2015
91
0.030
Why?
Nuclear Cap-Binding Protein Complex
1
2014
1
0.030
Why?
Medication Adherence
1
2018
467
0.030
Why?
Patient Selection
1
2018
696
0.030
Why?
Ubiquitins
1
2014
36
0.030
Why?
Ribosomal Protein S6 Kinases, 90-kDa
1
2014
14
0.030
Why?
Guanosine
1
2014
41
0.030
Why?
Interferons
1
2016
202
0.030
Why?
Rapamycin-Insensitive Companion of mTOR Protein
1
2014
28
0.030
Why?
Dose-Response Relationship, Drug
1
2018
2057
0.030
Why?
Health Care Surveys
1
2016
565
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2014
121
0.030
Why?
Risk
1
2016
912
0.030
Why?
Recombinant Fusion Proteins
1
2016
665
0.030
Why?
Microbial Sensitivity Tests
1
2015
361
0.030
Why?
Mutation, Missense
1
2015
341
0.030
Why?
Eukaryotic Initiation Factor-4E
1
2013
27
0.030
Why?
Cell Line, Transformed
1
2013
145
0.030
Why?
U937 Cells
1
2012
24
0.020
Why?
Gene Knockdown Techniques
1
2014
327
0.020
Why?
Randomized Controlled Trials as Topic
1
2018
1477
0.020
Why?
Aspirin
1
2015
387
0.020
Why?
Multivariate Analysis
1
2016
1509
0.020
Why?
Embryo, Mammalian
1
2012
232
0.020
Why?
Hospitalists
1
2016
245
0.020
Why?
Patient Outcome Assessment
1
2013
131
0.020
Why?
Epigenesis, Genetic
1
2016
660
0.020
Why?
Logistic Models
1
2016
2074
0.020
Why?
Pregnancy
1
2023
6763
0.020
Why?
Leukemia
1
2013
240
0.020
Why?
Vascular Diseases
1
2013
243
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2012
430
0.020
Why?
Splanchnic Circulation
1
2009
10
0.020
Why?
Infarction
1
2009
10
0.020
Why?
Plasmapheresis
1
2009
24
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
86
0.020
Why?
Antibody Specificity
1
2009
189
0.020
Why?
Blood Specimen Collection
1
2008
41
0.020
Why?
Giant Cell Arteritis
1
2009
49
0.020
Why?
Mice, Inbred C57BL
1
2019
5757
0.020
Why?
Tretinoin
1
2009
123
0.020
Why?
Fatal Outcome
1
2009
303
0.020
Why?
Immunoassay
1
2008
115
0.020
Why?
Rituximab
1
2009
176
0.020
Why?
Risk Assessment
1
2017
3457
0.020
Why?
Plasma
1
2008
212
0.020
Why?
Spleen
1
2009
514
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
1692
0.020
Why?
Hospitalization
1
2016
2199
0.020
Why?
Internship and Residency
1
2016
1147
0.020
Why?
Cell Differentiation
1
2013
1991
0.010
Why?
Cross-Sectional Studies
1
2016
5472
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2003
283
0.010
Why?
Tumor Cells, Cultured
1
2003
955
0.010
Why?
United States
1
2018
14841
0.010
Why?
Kidney
1
2009
1468
0.010
Why?
Liver
1
2009
1943
0.010
Why?
Base Sequence
1
2003
2181
0.010
Why?
Molecular Sequence Data
1
2003
2900
0.010
Why?
Adolescent
1
2015
21513
0.010
Why?
DNA-Binding Proteins
1
2003
1502
0.010
Why?
Mcmahon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)